Author:
Storck M.,Prestel R.,Hammer C.,Abendroth D.
Publisher
Springer Berlin Heidelberg
Reference8 articles.
1. Isobe M, Yagita H, Okumura K, Ihara A (1992) Specific acceptance of cardiac allograft after treatment with autoantibodies to ICAM-1 and LFA-1. Science 255: 1125–1127
2. Haug CE, Colvin RB, Delmonico FL, Auchincloss H, Tolkof-Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmid L, Cosimi B (1993) A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55: 766–773
3. Hourmant M, Bedrossian J, Durand D, Kessler M, Lebranchu Y, Caudrelier P, Simi B, Soulillou SP (1995) Multicenter comparative study of an anti-LFA-1 adhesion molecule monoclonal antibody and antithymocyte globulin in prophylaxis of acute rejection in kidney transplantation. Transplant Proc 27: 864
4. Kelly KJ, Williams WW, Colvin RB, Bonventre JV (1994) Antibody to intercellular adhesion molecule 1 protects the kidney against renal failure. Proc Nat Acad Sci 91: 812–816
5. Prestel R, Storck M, Pooth R, Steinbach G, Hammer C, Abendroth D (1996) Na-K/2C1 transporter inhibition for reduction of postischemic kidney failure tested in autologous reperfusion. Transplant Int 9 (suppl.l): 437–441